Observation and execution of upper-limb movements as a tool for rehabilitation of motor deficits in paretic stroke patients: protocol of a randomized clinical trial by Ertelt, Dennis et al.
Ertelt et al. BMC Neurology 2012, 12:42
http://www.biomedcentral.com/1471-2377/12/42STUDY PROTOCOL Open AccessObservation and execution of upper-limb
movements as a tool for rehabilitation of motor
deficits in paretic stroke patients: protocol of a
randomized clinical trial
Denis Ertelt1, Claudia Hemmelmann2, Christian Dettmers3, Andreas Ziegler2 and Ferdinand Binkofski4*Abstract
Background: Evidence exist that motor observation activates the same cortical motor areas that are involved in the
performance of the observed actions. The so called “mirror neuron system” has been proposed to be responsible
for this phenomenon. We employ this neural system and its capability to re-enact stored motor representations as
a tool for rehabilitating motor control. In our new neurorehabilitative schema (videotherapy) we combine
observation of daily actions with concomitant physical training of the observed actions focusing on the upper
limbs. Following a pilot study in chronic patients in an ambulatory setting, we currently designed a new
multicenter clinical study dedicated to patients in the sub-acute state after stroke using a home-based self-induced
training. Within our protocol we assess 1) the capability of action observation to elicit rehabilitational effects in the
motor system, and 2) the capacity of this schema to be performed by patients without assistance from a
physiotherapist. The results of this study would be of high health and economical relevance.
Methods/design: A controlled, randomized, multicenter, paralleled, 6 month follow-up study will be conducted on
three groups of patients: one group will be given the experimental treatment whereas the other two will
participate in control treatments. All patients will undergo their usual rehabilitative treatment beside participation in
the study. The experimental condition consists in the observation and immediate imitation of common daily hand
and arm actions. The two parallel control groups are a placebo group and a group receiving usual rehabilitation
without any trial-related treatment. Trial randomization is provided via external data management. The primary
efficacy endpoint is the improvement of the experimental group in a standardized motor function test (Wolf Motor
Function Test) relative to control groups. Further assessments refer to subjective and qualitative rehabilitational
scores. This study has been reviewed and approved by the ethics committee of Aachen University.
Discussion: This therapy provides an extension of therapeutic procedures for recovery after stroke and emphasizes
the importance of action perception in neurorehabilitation The results of the study could become implemented
into the wide physiotherapeutic practice, for example as an ad on and individualized therapy.* Correspondence: fbinkofski@ukaachen.de
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Studies on primates and a growing number of electro-
physiological and imaging studies in humans provided
evidence that observation–dependent activation of
motor areas is mediated by the so called “mirror neu-
rons” [1-3]. These neurons discharge both when a goal-
directed action is performed and when the same or a
similar action is observed being performed by another
human [1,2]. Action observation is supposed to induce a
re-enactment of similar actions stored in human brains
[4-6] possibly by inducing simulation of the ongoing
actions [7]. It is likely that action observation leads to
organisational changes in the brain [4] and may partici-
pate via the mirror neuron system (MNS) in learning of
motor skills [8]. Concluding from these findings, we
assumed that the MNS has the capacity to stimulate the
cerebral motor areas by the observation of external
movements. Physiological studies clearly show that ob-
servation of congruent actions significantly facilitates
learning of basic movements in stroke patients and that
movement execution alone or movements execution
combined with observation of non-congruent actions
have no such effect [9].
Basing on these results we conducted a pilot study, in
which we established a novel physiotherapeutic scheme,
the so called "videotherapy", combining action observa-
tion with action execution for rehabilitation of motor
deficits after stroke [10-13]. We arranged our thera-
peutic scheme in a way that it would allow the most
possible unhindered activation of the MNS by focused
action observation. Further on, we included physical
exercises to strengthen any activation effects on the
motor areas thus permitting and reinforcing cerebral
reorganization. Our study was designed to test for the
direct top-down stimulation effect of motor observation
on the treatment of chronic motor arm deficit after
stroke. Based on the previous experiences using mental
techniques in neurorehabilitation [14] we combined ac-
tion observation with the direct effects of the top-down
action execution. Our hypothesis was that the activation
of motor areas by action observation becomes reinforced
by the concomitant execution of the observed actions
[15]. Therefore, action observation, along with
reinforcement by actual action execution, should be a
powerful tool in neurorehabilitation. The results of this
pilot study [10-13] confirmed this prediction. In this
study we used a design with one treatment (n = 8) and
one control group of post stroke patients (n = 8) in a
chronic stage with mild to moderate arm paresis. The
experimental condition consisted in watching video clips
containing daily activities and in imitating these activ-
ities with the paretic limb directly afterwards. The con-
trol condition matched the treatment condition, except
for watching slideshows of geometric symbols instead ofmovements. The main statistical analysis showed a
highly significant improvement in all experimental group
members during the course of treatment as evident from
the objective (Wolf Motor Function Test WMFT [16]:
p = 0.009; Frenchay Arm Test FAT [17]: p = 0.007;
Wilcoxon-Rank-Sum-Test) and the subjective (Stroke
Impairment Scale SIS [18]: p = 0.013) scales. The control
group of patients did not show noticeable improvement
during the course of the training (WMFT: p = 0.288;
FAT: p = 0.159; SIS: p = 0.131; Wilcoxon-Rank-Sum
-Test). The direct comparison between the treatment
and control groups confirmed that a better improvement
of the motor skills was acquired in the treatment group
compared to the control group (WMFT: p< 0.05; FAT: p
< 0.001; SIS: p< 0.003; Mann–Whitney-U-Test). Add-
itionally, the effects of action observation therapy on the
reorganization of the motor system were investigated by
functional magnetic resonance imaging (fMRI) using an
independent sensorimotor task containing object ma-
nipulation [10-13]. The major result of the fMRI study
was revealed by direct comparison of the changes in
neural activation during the course of the treatment be-
tween the experimental and the control groups. This
contrast yielded a significant rise in activation in the bi-
lateral ventral premotor cortex, bilateral superior tem-
poral gyrus, the supplementary motor area (SMA) and
the contralateral supramarginal gyrus. Our results sug-
gest that action observation, by reactivating those motor
areas which contain the action observation-execution
matching system, has a positive additional impact on re-
covery of motor functions after stroke.
Furthermore, recent publications stated that only the
non-affected hemisphere could be stimulated by mental
techniques, like motor imagery [19,20]. These studies
further described that mental techniques facilitate recov-
ery only in left-hemispheric strokes, and not in right-
hemispheric strokes. To investigate this issue we tested
stroke patients using fMRI and the aforementioned para-
digm of action observation [11]. As opposite to these
results, our own data obtained from eight right-
hemispheric and eight left-hemispheric stroke patients
revealed that both the affected as well as the non-
affected hemisphere were activated by action observation
[21,22]. This result represents a further important pre-
requisite for application of the videotherapy [23].
In sum, in the field of stroke rehabilitation, the
videotherapy represents a treatment of motor impair-
ments based on a clear physiological principle - the mir-
ror neuron system. The ambulatory clinical pilot and
our further studies on patient dedicated interventions let
us assume the feasibility and effectiveness of a training
session using action observation and physical imitation.
The planned trial will examine the following hypoth-
eses: 1. for stroke patients in sub-acute state, observation
Table 1 Inclusion and exclusion criteria
Inclusion criteria
Patients that are both psychically and physically eligible, with good
general state of health and nutritional condition for experimental
treatment both in the intensity and duration planned in the
presented trial (decided by the investigator).
Hospitalized patient: discharge from rehabilitation within the
following seven days (patient's data in the respective clinic)
Insult at least 4 weeks in the past, hemorrhagic stroke at least
6 month in the past (controlled via medical history, patient's data in
the respective clinic).
First clinically evident stroke so that the patient has no history of
stroke related trainings and treatments (controlled via medical history,
patient's data in the respective clinic, and note from the general
practitioner from outpatients, respectively).
Ischemic cortical or subcortical lesions in middle cerebral artery
territory or brain stem infarction resulting mainly in defined motor
impairments (controlled via medical history, patient's data in the
respective clinic, and note from the general practitioner from
outpatients, respectively).
Primarily motor symptoms with also primarily unilateral upper limb
paresis (controlled by standard neurological examination).
Minimal movement ability of the paretic limb (controlled by MRC
index ≥2 and ≤4: hand extension against gravity at wrist = 20° and at
metacarpophalangeal and interphalangeal joints of each of the
fingers = 10°) to participate in the treatments’ physical training tasks.
If any, only minimal aphasic symptoms allowing for understanding
and following instructions during test administration and treatment
(controlled by administration of the Token test≤ 21 incorrect
reactions).
If medication is needed: concomitant medication with effects on the
motor system, vigilance and/or cardiovascular system will be kept
unchanged throughout of the participation in the study (controlled
via discharge letter from hospitalized patients, and note from the
general practitioner from outpatients, respectively; as well as by
questioning the patient during the weekly telephone calls and the
assessments throughout the training phase).
Signed informed consent to participate in the trial.
EU-citizen for legal aspects of participation.
A DVD-Player is either in possession of the participant or is lent to
him by relatives or friends to allow participant to conduct the
treatment at home.
Exclusion criteria
Impaired level of consciousness that could prevent patient to
understand and follow instructions throughout the intervention, and
further result in inability to hold attentiveness and concentration to
the treatment (controlled via standard neurological examination,
subjective impression of the investigator during administration of test
inventory – i.e. patient is unable to understand and/or follow
instructions).
Severe untreated psychiatric disorder, severe pulmonary or
cardiovascular disease, or epilepsy that could lead to reduced abilities
to participate in the treatments’ task (controlled via discharge letter
from hospitalized patients, and note from the general practitioner
from outpatients, respectively). If any of the referred diseases is
treated with allowed stable medication, patient may not be excluded
from study participation.
Severe joint deformity of arthritic origin or chronic pain that could
reduce significantly the patient's abilities to perform tasks that
demand a functional physical execution, thus resulting in the
masking of expected training effects (controlled via standard
neurological examination).
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formance ("videotherapy") has a greater neurorehabilita-
tive effect than standard rehabilitation techniques alone,
2. Videotherapy has the advantage to be easily adminis-
tered at patient’s home who will perform it on her/his
own and without assistance of a physiotherapist.
Methods/design
Trial design
The form of our clinical study will be: multicenter, open,
randomized, placebo-controlled, paralleled group trial
with three investigative arms conducted in Germany (5
sites). This study aims at demonstrating superiority of
the videotherapy over both physical training and stan-
dardized physical therapeutic treatments. We will use
equal number of patients for the randomization on the
three groups (1:1:1).
Participants
In general, eligible participants will be all adults aged 30
or over with first clinically evident stroke, resulting in
primarily mild to moderate unilateral upper limb paresis.
Patients with more severe motor symptoms or further
medical or neuropsychological symptoms will not be eli-
gible to participate. See Table 1 for detailed inclusion
and exclusion criteria.
The multicenter study will take place at 5 sites in Ger-
many: Department of Neurology of University of Leipzig,
Department of Neurology of Brandenburg Klinik Bernau
near Berlin, Clinic for Neurology of at Campus Lübeck
University Medical Center Schleswig-Holstein, St. Maur-
itius Therapieklinik at Meerbusch near Düsseldorf, and
the Neurological Centre of Segeberger Kliniken GmbH
at Bad Segeberg. All sites represent the main venues for
stroke patients and stroke-related rehabilitation in their
surrounding areas, thus able to reach the expected sam-
ple size of stroke patients. Because the study centers at
Lübeck and Leipzig do not provide treatment for
patients in their post-stroke rehabilitation phase, these
sites will recruit patients from nearby rehabilitation cen-
ters to where their sub-acute patients have been referred
further on. Recruited patients therefore will have been
pre-screened at the respective site and will be invited at
the end of their rehabilitative treatment to the trial site
for participation. All recruitment formalities and ambu-
latory or stationary assessments will be conducted in the
sites stated above with patients transported to the re-
spective clinics.
Patients' data will be assessed in the respective sites.
Data management and monitoring of the trial sites will
be conducted by the Center for Clinical Trials, Univer-
sity of Lübeck. Biostatistical analysis and randomization
will be performed by the Institute of Medical Biometry
and Statistics, University of Lübeck. An independent
Table 1 Inclusion and exclusion criteria (Continued)
Motor problems not primarily unilateral or excessive pain in major
affected limb that could reduce the patient's abilities in tasks
requiring a functional physical execution, thus resulting in the
masking of expected training effects (controlled via standard
neurological examination).
Dementia symptoms that could prevail over the administration of
test inventories and treatment (controlled by administration of the
Mini-Mental-State Examination, MMSE, score≤ 22).
Depressive symptoms that could result in major difficulty of the patient's
motivational compliance to follow instructions and to participate in the
interventions’ tasks throughout the treatment (controlled by
administration of the Beck Depression Inventory, BDI, score≥18).
Apraxic symptoms that could lead to impaired abilities to follow
instructions (controlled by administration of the Florida Apraxia
Screening Test, FAST, ≤ 9 correct reactions).
Neglect symptoms that could lead to impaired abilities to participate
in the treatments observational tasks (controlled by administration of
the Albert’s Neglect Test, ANT, minimal 2 lines unchecked).
Actual neuroleptic treatment for psychiatric reasons; no constant
concomitant medication (controlled via discharge letter from
hospitalized patients, and note from the general practitioner from
outpatients, respectively).
Planned, but not actual treatment with psychotropic and/or
antiepileptic medication or, if already in treatment, change of dose of
the referred medications during the phase between the screening
and post-trial assessments (controlled via discharge letter from
hospitalized patients, and note from the general practitioner from
outpatients, respectively).
Planned start of other rehabilitation therapies that might interfere
with the trial treatment in the next eight weeks from time point of
recruitment.
Insufficient knowledge of German language to understand and fill in
the questionnaires (clinical judgment during standard neurological
examination).
Residence more than 300 kilometers from participating center that
would exacerbate the regular visits of the patient in the respective
center (controlled by questioning of the patient).
Persons who are accommodated in an institution by court or
administrative order (controlled by questioning of the patient).
Any other medically untreated illness or medical treatment or drug or
narcotics misuse that could interfere with the assessment of the safety,
tolerability and efficacy, e.g. current bone fractures of the stroke affected
limb (controlled via discharge letter from hospitalized patients, and note
from the general practitioner from outpatients, respectively).
Simultaneous participation in another (clinical) trial or interfering
examination or participation in a study within 90 days prior to screening.
People who are in a dependency/employment for the sponsor or
investigator (controlled by questioning of the patient).
Biological age <30.
Pregnancy or suspected pregnancy. Lack of safe contraceptive
measures.
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cians and a biostatistician will to supervise patients'
safety, as well as statistical analysis and interpretation.
Interventions
One experimental and two control groups will be built.
All patients of all groups will conduct their individualrehabilitational programme as prescribed by their re-
spective neurologist beside participation in our scheme.
The standard rehabilitational programs will not be lim-
ited in their amount to allow participation to our study
but must not be experimental or part of another clinical
trial.
The respective intervention starts with a practice at
the site during the last week at their inpatient stay.
Patients will be asked to start immediately with the self-
administered treatment after their return back home. All
patients will keep record of their training in a pre-
printed diary and will receive a weekly phone call in
which compliance of the patients will be monitored.
Experimental condition (abbr. "videotherapy")
The experimental treatment in condition videotherapy
will consist of daily focused observation of actions and
subsequent practice of these actions for 6 weeks with
therapeutic session on each working day lasting 90 min-
utes. The treatment material will consist of 1 DVD con-
taining a set of video clips for each patient. These video
clips will show dedicated hand and arm actions with
household objects, each presented from different per-
spectives and each lasting for 6 minutes. The total dur-
ation of the treatment program will be 90 minutes per
working day, the patient will be informed by a manual
each day which set of films he/she has to watch. After
watching each single video clip, the patient will be asked
automatically by the DVD program to imitate the
observed action using his/her own household objects
with his/her paretic hand.
Our therapeutic scheme (videotherapy) was invented
to rule out most confounding variables of the training.
More precisely, 1) the therapy should elicit the most
possible unhindered activation of the MNS and 2) each
patient should as far as possible benefit from the thera-
peutic setting.
To achieve this goal we implemented the following
features to our treatment:
1. Observation of well-known, non-complex hand and
arm actions related to small common household
objects, performed by one hand, will be the key
feature of the therapy. Attentive watching of well-
known actions will allow the patient-observer to
comprehend their content and take details of those
actions. The high familiarity and recall level of the
observed actions, which belong to an average motor
behavioral repertoire, allows the activation of
predefined movement patterns in the patient's motor
system. This should be the prerequisite for an
internal simulation of the observed actions, which
refers to a covert rehearsal of motor actions and is
believed to ameliorate the subsequent overt action
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capability to induce rehabilitation effects by
stimulating cerebral reorganization, as demonstrated
in our pilot studies [10-13]. The video clips for the
current study are mainly derived from an already
evaluated pool that has been used in our pilot
studies [10-13]. An assessment of the films'
presented movement complexity allowed creating
sequences of video clips with alternating difficulty
(easy – difficult) for every day of training. Therefore,
highly and moderate affected stroke patients will be
able to perform at least some of the actions without
getting over- or underchallenged.
2. To provide comparability of results and to avoid
variability in the amount of observed actions we
decided to use standardized video clips of object
related movements as treatment material. Video
clips will be presented from a DVD disk, a user-
friendly medium that can be copied in virtually
infinite quantities. Further on, DVD players are
common and can be found in almost every patient's
household.
3. The therapeutic schema of the videotherapy will
consist of observation and consecutive training of
the observed actions. We assume that the activation
of the MNS by action observation should be
reinforced by the consecutive execution of the
observed actions. This combination should finally
elicit effects of plasticity in the motor system. Our
treatment schema is based on this effect: After the
end of each video clip, the patient will be asked to
imitate for 6 minutes the actions seen before using
similar objects from his or her own household. Only
the affected arm and affected hand will be used. The
patient will be informed during watching of the
DVD films, when to start and when to stop the
training and when to take a break.
Control condition I (abbr. "non-video")
The treatment material for the control condition non-
video will be equivalent to the experimental treatment,
except for the fact that slideshows of geometric symbols
will be shown instead of actions. These slideshows have
been proven not to elicit any activity in the motor areas
[10-13] and were therefore chosen as placebo treatment.
Control condition II (abbr. "standard")
No specific experimental treatment is intended for the
standard-condition. However, this group's patients will
receive the same schedule of assessments as the other
groups and will participate in their standard rehabilita-
tional treatments.
Further on, the patients of the non-video and the
standard group will receive (additionally) the sametreatment disk after the end of the individual training
phase. In this, all patients, independent from their group
allocation, will have the same treatment material that is
believed to be effective for stroke rehabilitation. This is
1) to allow all patients to benefit from the therapy posi-
tively tested in the several pilot studies [10-13], and 2) to
maintain compliance of the patients, even for being in
the standard group and not receiving in the first 6 weeks
of participation a special treatment.
Risks associated with the participation in the clinical trial
There are no known risks associated with the videother-
apy or any of the two control conditions. Due to the
self-administration of the treatment in dose, place, time
etc. the individual patient has the potential possibility to
regulate the treatments properties for his or her own
convenience. Further on, our pilot studies (10–13) did
not indicate any risks in the treatment, its materials or
in its conduction. The same is true for the used control
conditions.
Outcomes
All outcome measures and assessment time points for
patients are listed in Table 2.
Primary endpoint
The primary efficacy endpoint is the change in scores of the
WMFT [16] between baseline and after six weeks of re-
habilitation treatment between the videotherapy group, the
standard and videotherapy group and the non-video group.
Secondary endpoints
The secondary endpoints concern quality of life related
to improvement in motor function indices (tested via
FAT, 17) and autonomy (tested via SIS [18], Barthel-
Index - BI [24], Modified Rankin Scale - MRS [25],
Motor Activity Log – MAL [26], Box and Block Test -
BBT [27]). A secondary endpoint is the change in the
WMFT [16] scores between baseline and after end of
the treatment compared to the non-video and standard
groups. The changes in the scores and mortality between
all groups at all time points will be tested pairwise. Fur-
thermore, the difference between the end of treatment
and 6 month after the training will be investigated
within each group.
Subgroup analysis
We will perform pairwise comparisons between all groups
(videotherapy, non-video and standard) in dependency of
the following variables: center, age, gender, race, domin-
ance of the affected hemisphere, affected hemisphere, type
and amount of additional physio- and/or occupational or
other therapeutic treatments during training phase, chron-
icity/sub-chronicity of stroke symptoms. Chronicity is
Table 2 Outcome measures, assessments, and frequency and scope of study visits
Visit Screening Instruction(Videotherapy
and Non-Video Group)
Baseline Training phase End of
Training
Follow-up
Time Week 1: Day 1-3 Week 1: Day 4-5 Week 2 Week 2 – 7+ 4 days Week 8+ 4 days Week 31+ 1 week
Screening, supervision
Informed consent X
Inclusion/exclusion criteria X
Background medical history X
Concomitant medication X
Screening X
Beck Depression Inventory X X X (week 5) X X
Amount of training
with videotherapy DVDs
X
Preparation of patient
Instruction and training X
Primary efficacy endpoint
Wolf Motor Function Test X X X
Secondary efficacy endpoint
Frenchay Arm Test X X X
Stroke Impact Scale X X X
Barthel-Index X X X (week 5) X X
Modified Rankin Scale X X X X
Motor Activity Log X X (week 5) X X
Box and Block Test X X X
Further treatment
Telephone calls Weekly
Diary Daily by the patient
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symptoms≥ 6 months after the incident.
Further assessments
Besides the assessment of the outcome measures as listed
above, several additional assessments will be conducted
for screening reasons (Background medical history, In-
take/prescription of concomitant medications, standard
neurological examination, Florida Apraxia Screening Test
- FAST [28], Albert's Neglect Test - ANT [29], Mini Men-
tal Status Examination - MMSE [30], Edinburgh Handed-
ness Inventory - EHI [31], Beck Depression Inventory -
BDI [32], Modified Medical Research Council Scale for
measuring hand muscles - MRC-Index [33]). The BDI
[32] will be conducted throughout all assessment time
points due to the fact that depressive symptoms can
evolve in all phases of the study and can therefore prevent
an unhindered conduction of the training.
Sample size
The calculation of the sample size is based on the aim to
detect a difference of 2.5 points in the WMFT [16]between the videotherapy- and the standard group con-
cerning the change from baseline until the end of re-
habilitation, corresponding to δ= 0.5, with a power of
90% in the final of two analyses. The critical difference
of 2.5 points in the WMFT [16] results from our pilot
study [10-13]. Allowing for a maximal drop out of 20%
of the patients, 125 patients need to be included in the
study for each group, rendering a total sample size of
375 (α2(1) = 0.035, Mann–Whitney test).
The interim analysis is conducted according to Wang
and Tsiatis [34], after half of the patients in each group
(63 in each group, a total of 188) have concluded the re-
habilitation program. If the effect is considerably greater
than assumed (δ= 0.7, corresponding to a difference of
3.5 change points), there is a probability of 80% to detect
this at this early stage and hence to terminate the study
early.Randomization: sequence generation
According to Nordle and Brantmark [35], a self-
adjusting randomization plan with an allocation prob-
ability of 0.9 is utilized with stratification for center as
Table 3 Procedure of statistical analysis
Analysis
i
Time
point
Hypothesis Nominal
level αi
Detectable
effect δi
Power
1 Interim
analysis
Video vs.
standard
0.01 0.7 80%
Video vs.
non-video
0.01 0.7 80%
2 Final
analysis
Video vs.
standard
0.035 0.5 90%
Video vs.
non-video
0.01 or
0.045
0.47 or 0.55 90%
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2, 3, and 4) [33] as the less important factor.
Randomization: implementation
The allocation of patients will be conducted by an investi-
gator without any clinical involvement in the trial using
proper random sequences unbeknown to the patients or
study team: The randomization and further allocation is
performed centrally via fax at the Institute of Medical Bi-
ometry and Statistics at the University Hospital Schleswig-
Holstein, Campus Lübeck, Germany (IMBS) after the re-
spective investigator had screened the respective patient
and obtained his/her written informed consent.
Blinding
Participants are to be enrolled by the respective trial
sites' personal.
Participating patients can only be blinded for the com-
parison of the videotherapy versus the non-video condi-
tion, but not for the comparison with the standard
rehabilitation. Hence, comparing videotherapy with stand-
ard might be biased by the knowledge of the patients to
receive a novel treatment. In addition, the intensity of re-
habilitation will be comparable between the videotherapy
and the non-video group, but not necessarily between
both motor exercise groups and the standard group.
Therefore, a difference between videotherapy and stand-
ard might be caused by a more intense training in the first
group. These possible influences will have to be consid-
ered in the interpretation of possible study outcomes.
Statistical analysis
Study population
According to the "ICH Topic E 9" there are two different
sets (intention to treat set and per protocol set) for the
statistical analysis.
The primary analysis will be based on the intention to
treat population where missing values will be imputed with
a mean imputation. Similar rates of missing baseline obser-
vations between the treatment groups as well as analogous
results from sensitivity analyses will be used to support the
interpretation. As sensitivity analyses, the imputation meth-
ods "Last Observation Carried Forward" principle and best
or worst case imputation will be applied.
A secondary analysis will be based on the per protocol
population. Here we consider only patients which complete
at least 66,67% of the training sessions. This value is derived
from the pilot study [10], where significant treatment effects
occurred after duration of 20 training days. The analyses
will be the same as with the intention to treat.
Primary endpoint
The score difference cannot be assumed to be normally
distributed, so that distributions will be compared byanalyzing the probability that an observed change score
XVideotherapy in the videotherapy population is greater
than an observation in the non-video XNon-video or the
standard population XStandard:
H0 1ð Þ : P XVideotherapy>XStandard
 
¼ 1 2versusH1 1ð Þ : P XVideotherapy>XStandard
  6¼ 1 2=

and
H0 2ð Þ : P XVideotherapy>XNonvideo
 
¼ 1 2versusH1 2ð Þ : P XVideotherapy>XNonvideo
  6¼ 1 2=

The comparisons will be performed in a hierarchical
manner according to a suggestion by Wiens [36,37]. For
this procedure, the total significance level α is split into
one portion for the first hypothesis α(1) and one for the
second hypothesis α(2) = α – α(1). Accordingly, as we ex-
pect a major difference between the novel video-based
rehabilitation and the standard physiotherapeutic re-
habilitation, this difference will be tested first at the sig-
nificance level α(1). If the null hypothesis can be
rejected, we will secondly test the difference between
videotherapy and non-video at the full significance level
α. However, if the first hypothesis cannot be rejected,
the second hypothesis can still be tested at the signifi-
cance level α(2). The hypotheses will be tested using the
exact U-test according to Mann and Whitney, and the
specific significance levels are fixed using a sequential
analysis plan (see Table 3).
Secondary endpoints
The analysis of the secondary endpoints will be per-
formed exploratory. The hypothesis
H0 3ð Þ : P XNonVideo > XStandardð Þ
¼ 1 2versusH1 2ð Þ : P XNonvideo > XStandardð Þ 6¼ 1 2=

will be tested using the exact U-test according to Mann
and Whitney at the significance level α= 0.05. The
change scores of the BBT, MAL, SIS, FAT, MRS, and BI
as well as the WMFT and mortality between groups at
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test according to Mann and Whitney and Chi-squared
test respectively at the significance level α= 0.05. The ef-
fect measures will be the difference of medians with 95%
confidence interval (Hodges-Lehmann) and the differ-
ence of proportions with 95% confidence interval (inde-
pendent samples), respectively. Furthermore, the
difference between end of training and 6 month after the
training will be investigated within each treatment group
concerning the BBT, MAL, SIS, FAT, MRS, and the BI as
well as the WMFT scores. Therefore, 95% confidence
intervals are computed for these differences (paired
samples).
Subgroups
In the subgroup analyses the results of the test inventor-
ies and assessments stated above are used.
Interim analyses
After half of the patients have concluded the rehabilita-
tion program, an interim analysis will be performed.
This will allow for an early termination of the study if
the effects are greater than assumed for sample size de-
termination while keeping an overall significance level of
α= 0.05. The interim analysis is planned according to
the designs suggested by Wang and Tsiatis [34] and
yields a nominal significance level of α1 = 0.01 for the in-
terim analysis. At this time point, all three null hypoth-
eses regarding the primary endpoint as stated above are
tested at the full nominal significance level, and the
study is terminated only if all null hypotheses are
rejected.
For the final analysis, the three hypotheses of the pri-
mary endpoint are tested at a nominal significance level
of α2 = 0.045 in the hierarchical manner described above.
Specifically, the first hypothesis is tested at a significance
level of α2(1) = 0.035. If this null hypothesis is not
rejected, the second null hypothesis is tested at the
remaining significance level of α2(2) = 0.01. However, if
the first null hypothesis is rejected, the second is tested
at the full nominal significance level of α2 = 0.045.
This procedure renders the following effects detectable
in the different stages, as presented in Table 3. The
effects are measured by the differences of medians, for
which 95% confidence intervals (Hodges-Lehmann) are
computed for both group comparisons.
Criteria for termination of the study
The study can be terminated prematurely if circum-
stances become known that suggest a significant deteri-
oration in the expected benefit-to-risk ratio of either
study arm in comparison to the other. The DSMB will
monitor any safety issues of the trial and will make a
recommendation based on their evaluation.In the event of substantial and irreparable deficiencies
in data quality, inadequate compliance, or deficient pa-
tient recruitment, the study can be terminated prema-
turely: The DSMB will monitor these issues to make a
recommendation for a premature termination, if a con-
clusion regarding the study question can no longer be
expected to be reached on the basis of the data.
Further on, an early termination of the study will be
made, if the statistical effects for testing the statistical
hypotheses are greater than assumed for sample size de-
termination; these effects will be calculated by the
planned interim statistical analysis.Ethical approval and registration
This study has been reviewed and approved by the med-
ical ethics committee of the RWTH Aachen university,
Aachen, Germany (reference no.: 106/10) and has been
registered at ClinicalTrials.gov (identifier:
NCT01242956) Patients receive verbal and written infor-
mation about the study and written informed consent
will be obtained before randomization.Discussion
The proposed treatment, based on the neurophysio-
logical principle of the mirror neuron system, provides a
new and relevant extension of therapeutic procedures
for recovery after stroke. The results of the planned mul-
ticenter study might be implemented to the standard
concepts of physiotherapeutic practice, for example as
an add-on therapy. Therefore, the results of our study
should be of great interest for the community of neurol-
ogists and physiotherapists and most relevant for health
economy.
The planned multicenter project will introduce novel
aspects to the rehabilitation of stroke. First, focused obser-
vation of goal-directed actions before their execution con-
stitutes a novel aspect in the treatment of motor deficits
after stroke. Action observation activates central represen-
tations of actions through the mirror neurons system. The
subsequent repetitive execution of the observed actions
reinforces the cortical representation of action. The mirror
neuron system provides a clearly defined neurophysiologic
background for this new approach. Second, the new treat-
ment is aimed at patients in the sub-acute state after
stroke. However, it should also be beneficial for severely
handicapped patients in the acute state, when applied
prior to physiotherapy. Therefore, because activation of
action representations by observation takes place also
without the performance of active movements, this new
therapy is also potentially suitable for patients with acute
strokes. Thirdly, the videotherapy can be focused on the
individual pattern of motor impairments in the future. In
times of restricted resources in the health system, it is of
Ertelt et al. BMC Neurology 2012, 12:42 Page 9 of 10
http://www.biomedcentral.com/1471-2377/12/42paramount importance to develop cost-efficient rehabilita-
tion programs.
Additionally, one of the major goals of this proposal is
to implement a home-based practice program for patients
and to evaluate its effectiveness. Another potential advan-
tage of this home-based treatment is that patients are edu-
cated to carry responsibility for their future well-being.
They are trained to perform exercises on their own. This
is in line with current trends in the health system to treat
the patient as responsible partner able for shared decision
making. Up to date there exists no rationale for selecting
the appropriate physiotherapeutic regime in a particular
individual patient. Improving our understanding, how and
where different therapeutic strategies work or act in the
brain, will optimize the rational basis for applying different
therapies.
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